🔎 Trials Near Me

Acasă › Anemie falciformă › Pennsylvania

Studii clinice pentru Anemie falciformă în Pennsylvania

20 studii pentru Anemie falciformă caută participanți în Pennsylvania.

Orașe în Pennsylvania

Text oficial al studiului (în engleză)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Spoknwrdclinicaltrials, Easton
  • Thomas Jefferson University Me, Philadelphia
În curs de recrutareFaza 3
Vârste de la 12 la 100 · Toate sexele · Actualizat 28 sept. 2026 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • University of Pittsburgh Medical Center (UPMC), Pittsburgh
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT07187973

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Children's Hosptl Philadelphia, Philadelphia
  • St Christopher Hosp for Child, Philadelphia
În curs de recrutareFaza 3
Vârste de 12 ani și peste · Toate sexele · Actualizat 17 sept. 2026 · NCT06612268

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  • Childrens Hospital Of Philadelphia, Philadelphia
În curs de recrutareFaza 1/2Voluntari sănătoși bineveniți
Vârste de la 12 la 55 · Toate sexele · Actualizat 9 sept. 2026 · NCT06546670

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Local Institution - 0029, Philadelphia
  • Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
  • Local Institution - 0032, Pittsburgh
În curs de recrutareFaza 1/2Voluntari sănătoși bineveniți
Vârste de 18 ani și peste · Toate sexele · Actualizat 18 aug. 2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Children's Hospital of Philadelphia, Philadelphia
  • Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
  • St. Christopher's Hospital for Children, Philadelphia
  • și încă 1
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 17 aug. 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • University of Pittsburgh, Pittsburgh
  • Hillman Cancer Center, Pittsburgh
În curs de recrutareFaza 2
Vârste de 12 ani și peste · Toate sexele · Actualizat 14 aug. 2026 · NCT06699849

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
În curs de recrutareFaza 1/2
Vârste de la 5 la 40 · Toate sexele · Actualizat 13 aug. 2026 · NCT03653338

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

  • Children's Hospital of Philadelphia, Philadelphia
În curs de recrutareFaza 1/2
Vârste de la 12 la 45 · Toate sexele · Actualizat 4 iun. 2026 · NCT07252050

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Children's Hospital of Philadelphia (MRD-HCT), Philadelphia
În curs de recrutareStudiu observațional
Vârste de la 3 la 20 · Toate sexele · Actualizat 4 iun. 2026 · NCT06941389

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

  • Children's Hospital of Philadelphia, Philadelphia
În curs de recrutareFaza 4
Vârste de la 18 la 50 · Femei · Actualizat 28 mai 2026 · NCT06665997

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

  • Children's Hospital of Philadelphia, Philadelphia
În curs de recrutare
Vârste de la 13 la 21 · Toate sexele · Actualizat 11 mai 2026 · NCT06290401

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

  • Children's Hospital of Philadelphia, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
În curs de recrutareFaza 2
Vârste de la 15 la 40 · Toate sexele · Actualizat 13 mar. 2026 · NCT06260891

Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease

  • University of Pennsylvania, Philadelphia
În curs de recrutare
Vârste de 18 ani și peste · Toate sexele · Actualizat 27 feb. 2026 · NCT07316478

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • Children's Hospital of Philadelphia, Philadelphia
În curs de recrutareStudiu observațional
Vârste de la 14 la 37 · Toate sexele · Actualizat 28 ian. 2026 · NCT07373639

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
În curs de recrutareStudiu observațional
2 Months – 60 Years · Toate sexele · Actualizat 13 ian. 2026 · NCT04528355

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • UPMC University of Pittsburgh Classical Hematology Adult Clinic, Pittsburgh
  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
În curs de recrutare
Vârste de la 16 la 30 · Toate sexele · Actualizat 7 ian. 2026 · NCT06374238

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
În curs de recrutareFaza 2
2 Months – 55 Years · Toate sexele · Actualizat 15 dec. 2025 · NCT01962415

Cutaneous Hydration Assessment in SCD

  • UPMC Sickle Cell Clinic, Pittsburgh
În curs de recrutare
Vârste de 12 ani și peste · Toate sexele · Actualizat 12 nov. 2025 · NCT05210114

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • University of Pennsylvania, Philadelphia
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 iun. 2025 · NCT06385886

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.